Biochemical Pharmacology 1983-07-15

On the metabolism of allopurinol. Formation of allopurinol-1-riboside in purine nucleoside phosphorylase deficiency.

S Reiter, H A Simmonds, D R Webster, A R Watson

Index: Biochem. Pharmacol. 32(14) , 2167-74, (1983)

Full Text: HTML

Abstract

Allopurinol-1-riboside, a major metabolite of allopurinol, is commonly thought to be directly synthesized by purine nucleoside phosphorylase (PNP) in vivo. As this enzyme is otherwise believed to function in vivo primarily in the direction of nucleoside breakdown, we have determined by high performance liquid chromatography and a conventional chromatographic method the urinary metabolites of allopurinol in a child deficient of PNP. In this patient approximately 40% of urinary allopurinol metabolites consisted of allopurinol-1-riboside, thus proving the possibility of indirect formation of allopurinol-1-riboside via allopurinol-1-ribotide in vivo, catalysed by hypoxanthine guanine phosphoribosyltransferase (HGPRT) and a phosphatase.


Related Compounds

Related Articles:

Activity of inosine analogs against Pneumocystis carinii in culture.

1986-07-01

[Antimicrob. Agents Chemother. 30(1) , 181-3, (1986)]

A tissue culture system for the growth of several species of Leishmania: growth kinetics and drug sensitivities.

1988-03-01

[Am. J. Trop. Med. Hyg. 38(2) , 304-7, (1988)]

Efficacy of pyrazolopyrimidine ribonucleosides against Trypanosoma cruzi: studies in vitro and in vivo with sensitive and resistant strains.

1984-10-01

[J. Infect. Dis. 150(4) , 602-8, (1984)]

Pharmacokinetics and metabolism of allopurinol riboside.

1991-05-01

[Clin. Pharmacol. Ther. 49(5) , 506-14, (1991)]

In vitro antileishmanial activity of inhibitors of steroid biosynthesis and combinations of antileishmanial agents.

1987-06-01

[J. Parasitol. 73(3) , 671-3, (1987)]

More Articles...